Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women
- PMID: 26322930
- PMCID: PMC4651022
- DOI: 10.1089/aid.2015.0151
Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women
Abstract
We investigated the Th1 protective and regulatory T and B cell (Treg and Breg) responses to pH1N1 monovalent influenza vaccine (IIV1) in HIV-infected pregnant women on combination antiretroviral therapy (cART). Peripheral blood mononuclear cells (PBMCs) from 52 study participants were cryopreserved before and after vaccination and analyzed by flow cytometry. pH1N1-specific Th1, Treg, and Breg responses were measured in PBMCs after in vitro stimulation with pH1N1 and control antigen. The cohort analysis did not detect changes in pH1N1-Th1, Treg, or Breg subsets postvaccination. However, individual analyses distinguished subjects who mounted vigorous Th1 responses postvaccination from others who did not. Postvaccination, high pH1N1-Th1 correlated with high pH1N1-Treg and Breg responses, suggesting that low influenza effector responses did not result from excessive vaccine-induced immune regulation. High postvaccination pH1N1-Th1 responses correlated with baseline high PHA- and pH1N1-IFN-γ ELISpot and circulating CD4(+)CD39(+)% and CD8(+)CD39(+)% Treg, with low CD8(+) cell numbers and CD19(+)FOXP3(+)% Breg, but not with CD4(+) cell numbers or HIV viral load. These data highlight the heterogeneity of T cell responses to vaccines in HIV-infected individuals on cART. Predictors of robust Th1 responses to IIV include CD8(+) cell numbers, T cell functionality, and circulating Breg and Treg.
Figures
Similar articles
-
Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.PLoS One. 2015 Apr 13;10(4):e0122431. doi: 10.1371/journal.pone.0122431. eCollection 2015. PLoS One. 2015. PMID: 25874544 Free PMC article.
-
High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).Hum Vaccin Immunother. 2013 May;9(5):957-68. doi: 10.4161/hv.23774. Epub 2013 Jan 31. Hum Vaccin Immunother. 2013. PMID: 23370281 Free PMC article.
-
Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.Hum Vaccin Immunother. 2015;11(9):2253-65. doi: 10.1080/21645515.2015.1051275. Epub 2015 Jun 19. Hum Vaccin Immunother. 2015. PMID: 26091502 Free PMC article.
-
Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth.PLoS One. 2015 Mar 18;10(3):e0118567. doi: 10.1371/journal.pone.0118567. eCollection 2015. PLoS One. 2015. PMID: 25785995 Free PMC article. Clinical Trial.
-
Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.Curr HIV/AIDS Rep. 2011 Sep;8(3):181-91. doi: 10.1007/s11904-011-0086-4. Curr HIV/AIDS Rep. 2011. PMID: 21710214 Review.
Cited by
-
The Role of Cluster of Differentiation 39 (CD39) and Purinergic Signaling Pathway in Viral Infections.Pathogens. 2023 Feb 8;12(2):279. doi: 10.3390/pathogens12020279. Pathogens. 2023. PMID: 36839551 Free PMC article. Review.
References
-
- Madhi SA, Maskew M, Koen A, et al. : Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: Double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis 2011;52:128–137 - PubMed
-
- Madhi SA, Kuwanda L, Venter M, and Violari A: Prospective cohort study comparing seasonal and H1N1(2009) pandemic influenza virus illnesses in HIV-infected children during 2009. Pediatr Infect Dis J 2014;33:174–176 - PubMed
-
- Black S, Nicolay U, Vesikari T, et al. : Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011,30:1081–1085 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials